human | Q5 |
P5243 | Canal-U person ID | visvikis-siest-sophie-101311532 |
P269 | IdRef ID | 101311532 |
P2798 | Loop ID | 645703 |
P496 | ORCID iD | 0000-0001-8104-8425 |
P1053 | ResearcherID | H-2324-2014 |
P214 | VIAF ID | 206059711 |
P185 | doctoral student | Abdelsalam Saleh | Q57074470 |
Said El Shamieh | Q57552233 | ||
Ndeye Coumba Ndiaye | Q79298942 | ||
Marc Rancier | Q84976271 | ||
P69 | educated at | French National Institute of Health and Medical Research | Q1474517 |
P108 | employer | French National Institute of Health and Medical Research | Q1474517 |
P735 | given name | ??? | Q14942517 |
??? | Q14942517 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q92263880 | 4th ESPT summer school: precision medicine and personalised health |
Q57249336 | 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3–5 October 2016 |
Q57996196 | A Multilocus Genotyping Assay for Cardiovascular Disease |
Q49170154 | A comparison of lifestyle, genetic, bioclinical and biochemical variables of offspring with and without family histories of premature coronary heart disease: the experience of the European Atherosclerosis Research Studies. |
Q28740367 | A genome-wide association search for type 2 diabetes genes in African Americans |
Q43894795 | A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism |
Q35024990 | A multilocus genotyping assay for candidate markers of cardiovascular disease risk |
Q47890685 | A new single nucleotide polymorphism genotyping method based on gap ligase chain reaction and a microsphere detection assay |
Q30559038 | A parametric copula model for analysis of familial binary data |
Q45285740 | A prospective study on the prevalence of metabolic syndrome among healthy french families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome |
Q67887100 | A rapid and reliable method for direct genotyping of codon 360 in the human apolipoprotein A-IV gene |
Q34897205 | A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk |
Q43749369 | APOC3, CETP, beta-fibrinogen and MTHFR are genetic determinants of carotid intim-media thickness (Stanislas cohort) |
Q43612626 | APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). |
Q43267776 | Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children Correlation with BMI and fatty acid content |
Q73827606 | Age- and sex-related reference values for serum adhesion molecule concentrations in healthy individuals: intercellular adhesion molecule-1 and E-, P-, and L-selectin |
Q45155423 | Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort |
Q31160120 | An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data |
Q57997232 | An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene |
Q51498161 | Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism. |
Q35799595 | Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults |
Q51039519 | Apo B signal peptide insertion/deletion polymorphism is involved in postprandial lipoparticles' responses. |
Q41193905 | Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. |
Q48494055 | Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. |
Q57997059 | Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls |
Q57996401 | Apolipoprotein E Level in Cerebrospinal Fluid Increases With Aging |
Q43915269 | Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner |
Q73048445 | Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study--dominance of the epsilon 2 allele? |
Q43862818 | Apolipoprotein E in apolipoprotein B (apo B)- and non-apo B-containing lipoproteins in 3523 participants in the Stanislas cohort: biological variation and genotype-specific reference limits. |
Q73171412 | Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group |
Q43878391 | Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations |
Q34093070 | Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses |
Q57995959 | Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project |
Q48484420 | Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry |
Q61654935 | Apolipoprotein E-epsilon 4 allele and Alzheimer's disease |
Q50867083 | Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. |
Q40456376 | Apolipoprotein E: an important gene and protein to follow in laboratory medicine |
Q43545528 | Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism. |
Q29547208 | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index |
Q44562478 | Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort |
Q51541675 | Association between angiotensin II type 1 receptor gene polymorphism and metabolic syndrome in a young female Iranian population. |
Q46089026 | Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort |
Q57996267 | Association of Apolipoprotein E Polymorphism and Concentration with Serum Lipids and Apo-lipoprotein Level in the Chinese fromShanghai |
Q53203000 | Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease. |
Q57994961 | Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort |
Q35043398 | Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children |
Q46061354 | Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors |
Q42791922 | Association study of gene polymorphisms involved in vascular alterations in elderly hypertensives with subjective memory complaints |
Q73070461 | Associations of apolipoprotein E concentration and polymorphism with lipids and apolipoprotein levels in Chinese from Beijing and Shanghai |
Q44809955 | Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population |
Q37880880 | Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy |
Q44308570 | Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort. |
Q54381132 | Biological and genetic factors associated with ABCB1 and pregnane-X-receptor expressions in peripheral blood mononuclear cells in the STANISLAS cohort. |
Q57611853 | Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort |
Q46901979 | Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: Results from the STANISLAS cohort |
Q44798939 | Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study |
Q67282550 | Biological factors affecting concentrations of serum LpAI lipoprotein particles in serum, and determination of reference limits |
Q50888264 | Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. |
Q45137480 | Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort |
Q43600213 | Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population. |
Q57996091 | Capillary electrophoretic analysis of recombinant human apolipoprotein E |
Q53424328 | Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 1. ApoE distribution between lipoproteins. |
Q37889427 | Cardiovascular diseases and genome-wide association studies |
Q37491073 | Cardiovascular diseases-related GNB3 C825T polymorphism has a significant sex-specific effect on serum soluble E-selectin levels |
Q46733368 | Cardiovascular risk-associated allele frequencies for 15 genes in healthy elderly French and Chinese |
Q53324676 | Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. |
Q43974372 | Changes in serum apolipoprotein and lipoprotein profile after alcohol withdrawal: effect of apolipoprotein E polymorphism |
Q44535752 | Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation |
Q30809437 | Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels. |
Q44301379 | Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study. |
Q35108524 | Childhood obesity is associated with shorter leukocyte telomere length |
Q57994495 | Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin |
Q57994506 | Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999 |
Q51575482 | Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. |
Q57611895 | Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms |
Q45750225 | Conference Scene: Systems biology and personalized health science and translation |
Q53088955 | Conference scene: pharmacogenomics: from cell to clinic (part 2). |
Q42619582 | Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study |
Q47361495 | Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: linkage with varicosis |
Q77525617 | DNA extraction and stability for epidemiological studies |
Q72407552 | DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population |
Q47197889 | DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study |
Q43815848 | Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study |
Q53234663 | Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. |
Q56893651 | Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis |
Q57994984 | Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population |
Q79186938 | Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients |
Q37515592 | Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: biological variations and importance of pre-analytical steps |
Q48232841 | Effect of LSR polymorphism on blood lipid levels and age-specific epistatic interaction with the APOE common polymorphism. |
Q50115571 | Effect of SLCO1B1 gene polymorphisms and vitamin D on statin-induced myopathy |
Q40438217 | Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells |
Q51560929 | Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study. |
Q44531633 | Effect of six candidate genes on early aging in a French population |
Q50998343 | Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal. |
Q43923209 | Environmental and genetic determinants of intima-media thickness of the carotid artery |
Q36760692 | Enzymes and pharmacogenetics of cardiovascular drugs |
Q64101383 | Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS) |
Q96170253 | Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration |
Q56879645 | Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk |
Q58209872 | Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases |
Q70331352 | Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis |
Q35196218 | Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels |
Q57994633 | Expression of inflammatory molecules and associations with BMI in children |
Q30683122 | Extension of variance components approach to incorporate temporal trends and longitudinal pedigree data analysis. |
Q44816656 | Factors of variation and reference intervals for serum GST activity: the Stanislas cohort study |
Q41234829 | Familial resemblance of plasma apolipoprotein B: the Nancy study |
Q73245641 | Familial studies on the genetics of cardiovascular diseases: the Stanislas cohort |
Q35042612 | Family studies: their role in the evaluation of genetic cardiovascular risk factors. |
Q57996565 | Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels |
Q51021100 | Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. |
Q44545654 | Family study of the relationship between height and cardiovascular risk factors in the STANISLAS cohort. |
Q57994846 | Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study |
Q73010208 | Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population |
Q68882682 | Frequency and effects of the apolipoprotein A-IV polymorphism |
Q57995016 | From human genetic variations to prediction of risks and responses to drugs and the environment |
Q33188294 | From transcriptomics to bibliomics |
Q28729063 | Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels |
Q57994734 | Functional genomics towards personalized healthcare |
Q57994588 | Functional genomics towards personalized healthcare and systems medicine |
Q57994862 | Genetic Polymorphism of CYP2C19 Gene in the Stanislas Cohort. A link with Inflammation |
Q73199102 | Genetic and environmental influences on left ventricular mass. A family study |
Q38046386 | Genetic biomarkers of hypertension and future challenges integrating epigenomics |
Q33341793 | Genetic determinants of blood pressure regulation |
Q41496109 | Genetic determinants of leucocyte telomere length in children: a neglected and challenging field |
Q44838781 | Genetic influences on blood pressure within the Stanislas Cohort |
Q43803761 | Genetic influences on lipid metabolism trait variability within the Stanislas Cohort |
Q36419139 | Genetic variants predisposing to cardiovascular disease |
Q57996321 | Genetics strongly determines the wall thickness of the left and right carotid arteries |
Q58618794 | Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders |
Q28307044 | Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations |
Q36435865 | Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans |
Q43949756 | Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies |
Q34578402 | Growing significance of myeloperoxidase in non-infectious diseases. |
Q57995053 | Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles |
Q36854315 | High sensitivity of laser-induced fluorescence detection in capillary gel electrophoresis for accurate apolipoprotein E genotyping |
Q74599356 | High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity |
Q71568778 | High-resolution separation of PCR product and gene diagnosis by Capillary gel electrophoresis |
Q44359835 | Homo- and hetero-complexes of exchangeable apolipoproteins in solution and in lipid-bound form. |
Q57995824 | Human Apolipoprotein E concentration in response to diseases and therapeutic treatments |
Q28240999 | Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders |
Q54398144 | Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels. |
Q44651976 | IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. |
Q40097383 | IL6R haplotype rs4845625*T/rs4537545*C is a risk factor for simultaneously high CRP, LDL and ApoB levels |
Q35354678 | Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels |
Q35882777 | Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. |
Q70289118 | Immunochemical study of the plasma low and high density lipoproteins in Tangier disease |
Q48388034 | Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients |
Q37139179 | Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary study |
Q36277978 | Inter-individual variation of inflammatory markers of cardiovascular risks and diseases |
Q57995217 | Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort |
Q50852418 | Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. |
Q57995947 | LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women |
Q46576906 | Leptin expression in Peripheral Blood Mononuclear Cells (PBMCs) is related with blood pressure variability |
Q40508503 | Lipid and lipoprotein genetic variability: an important contribution from the French health examination centers. |
Q73333477 | Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort |
Q57995070 | Meeting Report: From human genetic variations to prediction of risks and responses to drugs and the environment |
Q50911423 | Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. |
Q43135056 | Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences |
Q34212342 | Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus |
Q44171936 | Molecular pharmacophore determination of lipid lowering drugs with the receptor mapping method |
Q43663634 | Multilocus approach to cardiovascular risk |
Q41094614 | Multivariate genetic analysis of high density lipoprotein particles |
Q53256331 | Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study. |
Q44485540 | Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome |
Q83835656 | Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia |
Q28270700 | New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk |
Q51020366 | Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285. |
Q36122410 | Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity |
Q34221038 | Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals |
Q61942928 | O97 Des variants du gène MTNR1B du récepteur 2 à la mélatonine augmentent la glycémie et le risque de DT2 : un lien entre le rythme circadien et le diabète ? |
Q57996367 | Objectives, Design and Recruitment of a Familial and Longitudinal Cohort for Studying Gene-Environment Interactions in the Field of Cardiovascular Risk: The Stanislas Cohort |
Q44441372 | PON1-192 Phenotype and Genotype Assessments in 918 Subjects of the Stanislas Cohort Study |
Q57994776 | Parental precocious influences on offspring cardiovascular risk markers: an exploratory study in the STANISLAS Cohort |
Q92660694 | Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population |
Q64354468 | Personalised Medicine: The Odyssey from Hope to Practice |
Q57994790 | Personalized therapy and pharmacogenomics: future perspective |
Q38766498 | Pharmacogenomic challenges in cardiovascular diseases: examples of drugs and considerations for future integration in clinical practice |
Q57995102 | Pharmacogenomics and antihypertensive drugs: a path toward personalized medicine |
Q36326419 | Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers |
Q28171051 | Pharmacogenomics and drug response in cardiovascular disorders |
Q35127795 | Pharmacogenomics of Drugs Affecting the Cardiovascular System |
Q53090390 | Pharmacogenomics: from cell to clinic (Part 1). |
Q44981833 | Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors |
Q35949808 | Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases |
Q70320463 | Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis |
Q49658063 | Pleiotropy of ABO gene: correlation of rs644234 with E-selectin and lipid levels |
Q54649601 | Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study. |
Q83999277 | Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia |
Q33292739 | Preanalytical variations of proteic biomarkers |
Q43785238 | Protein-lipid interactions in reconstituted high density lipoproteins: apolipoprotein and cholesterol influence. |
Q44205301 | Rapid spectrophotometric method for serum glutathione S-transferases activity. |
Q74301567 | Relationship between E-selectin L/F554 polymorphism and blood pressure in the Stanislas cohort |
Q30655179 | Sample size calculations for classical association and TDT-type methods using family data |
Q57611892 | Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms |
Q44384141 | Serum total antioxidant status, erythrocyte superoxide dismutase and whole-blood glutathione peroxidase activities in the Stanislas cohort: influencing factors and reference intervals |
Q46011141 | Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study. |
Q68037513 | Signal peptide-length variation in human apolipoprotein B gene. Molecular characteristics and association with plasma glucose levels |
Q35934127 | Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies |
Q72021049 | Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolism |
Q37067797 | Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis |
Q57996039 | Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E |
Q24600520 | Study of the sequence tagged site (STS) in the beginning of human apo A4 gene region |
Q45171999 | Synthesis and in vitro antioxidant activity of glycyrrhetinic acid derivatives tested with the cytochrome P450/NADPH system |
Q46319580 | Systems medicine, personalized health and therapy |
Q96117594 | TERC Variants Associated with Short Leukocyte Telomeres: Implication of Higher Early Life Leukocyte Telomere Attrition as Assessed by the Blood-and-Muscle Model |
Q41236879 | TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin |
Q60958793 | The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018 |
Q44838786 | The Leu554Phe polymorphism in the E-selectin gene is associated with blood pressure in overweight people |
Q37207278 | The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases |
Q46520615 | The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype |
Q72060165 | The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis |
Q71981668 | The frequency of the factor V gene R506Q mutation varies between regions of France |
Q47756265 | The future of telomere length in personalized medicine |
Q46813897 | The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study |
Q55017597 | The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-α levels and IMT-F. |
Q54244113 | The role of genetics in defining reference values and health status. |
Q52592956 | The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in |
Q46947785 | Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects |
Q40522986 | Two polymorphisms for amino acid substitutions in the APOA4 gene |
Q69266475 | Two-dimensional electrophoresis of plasma proteins and high density lipoproteins during inflammation |
Q91588366 | VEGF-A is associated with early degenerative changes in cartilage and subchondral bone |
Q68369749 | Variations in apolipoproteins serum amyloid A, A-I, A-II, and C-III in severely head-injured patients |
Q46772934 | Visfatin, low-grade inflammation and body mass index (BMI). |
Q47748241 | Visfatin: the link between inflammation and childhood obesity |
Q34584614 | What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? |
Q57995681 | Which Are the best Tools for Specific Clinical Application (Chips, Multiplex, Mass Spec Profile, etc.)? |
Q57995694 | Which, and How Limited Number of Polymorphisms Should Be Selected per Disease, Risk Assessment, Health Profile or Biological System? |
Q109309676 | Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants |
Q64914847 | [Alzheimer disease: hypotheses implicating apolipoproteins E]. |
Q68148035 | [Application of bidimensional electrophoresis in the determination of genetic variants] |
Q74563923 | [Association between E-selectin Leu554Phe polymorphism and blood pressure in the Stanislas cohort] |
Search more.